2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 3, 2001, Pages 973-977

  Tofovic, Stevan P ^a   Dubey, Raghvendra K ^a,b   Jackson, Edwin K ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; CHOLESTEROL; DRUG METABOLITE; ESTRADIOL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; PROTEIN;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ESTROGEN ACTIVITY; FLUID INTAKE; FOOD INTAKE; GLUCOSE URINE LEVEL; HEART PERFORMANCE; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RAT STRAIN; URINE VOLUME; VASCULAR DISEASE;

ANIMALS; ESTRADIOL; KIDNEY FAILURE; MALE; METABOLIC DISEASES; OBESITY; RATS;

EID: 0035192862     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Metabolic clearance rates of catechol estrogens in rats
2. Central role of the adipocyte in the metabolic syndrome
3. Economic costs of obesity and inactivity
4. 17β-estradiol, its metabolites and progesterone inhibit cardiac fibroblast growth
5. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms
6. Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms
7. Cardiovascular protective effects of 17β-estradiol metabolites
8. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism
9. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth
10. Estrogenic and antiestrogenic activities of 16α- and 2-hydroxy metabolites of 17β-estradiol in MCF-7 and T47D human breast cancer cells
11. Mechanisms of hypertension and kidney disease in obesity
12. Hypertension-related morbidity and mortality in the southeastern United States
13. Leptin-much more than a satiety signal
14. Phenylpropanolamine and the risk of hemorrhagic stroke
15. Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease
16. An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats
17. The continuing epidemic of obesity in the United States
18. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment
19. Leptin receptor missence mutation in the fatty Zucker rat
20. Syndrome X: 6 years later
21. Central nervous system control of food intake
22. Renal function and structure in diabetic, hypertensive, obese ZDF x SHHF-hybrid rats
23. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): Evidence for deficient plasmato-CSF transport of leptin in both the Zucker and Koletsky obese rat
24. Effects of estradiol and its metabolites on glomerular endothelial NO synthesis and mesangial cell growth
25. Increased 2-methoxyestradiol production in human coronary versus aortic vascular smooth muscle cells
26. Positional cloning of the mouse obese gene and its human homologue